211 related articles for article (PubMed ID: 36720754)
1. A Systematic Review of Health Economic Evaluations and Budget Impact Analyses to Inform Healthcare Decision-Making in Central America.
Rojas-Roque C; Palacios A
Appl Health Econ Health Policy; 2023 May; 21(3):419-440. PubMed ID: 36720754
[TBL] [Abstract][Full Text] [Related]
2. Barriers to generalizability of health economic evaluations in Latin America and the Caribbean region.
Augustovski F; Iglesias C; Manca A; Drummond M; Rubinstein A; Martí SG
Pharmacoeconomics; 2009; 27(11):919-29. PubMed ID: 19888792
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.
Sullivan SD; Mauskopf JA; Augustovski F; Jaime Caro J; Lee KM; Minchin M; Orlewska E; Penna P; Rodriguez Barrios JM; Shau WY
Value Health; 2014; 17(1):5-14. PubMed ID: 24438712
[TBL] [Abstract][Full Text] [Related]
5. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
6. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.
Mauskopf JA; Sullivan SD; Annemans L; Caro J; Mullins CD; Nuijten M; Orlewska E; Watkins J; Trueman P
Value Health; 2007; 10(5):336-47. PubMed ID: 17888098
[TBL] [Abstract][Full Text] [Related]
7. Systematic Review of Health Economic Evaluation Studies Developed in Brazil from 1980 to 2013.
Decimoni TC; Leandro R; Rozman LM; Craig D; Iglesias CP; Novaes HMD; de Soárez PC
Front Public Health; 2018; 6():52. PubMed ID: 29541630
[TBL] [Abstract][Full Text] [Related]
8. Exploring the cost-effectiveness of child dental caries prevention programmes. Are we comparing apples and oranges?
Anopa Y; Conway DI
Evid Based Dent; 2020 Mar; 21(1):5-7. PubMed ID: 32221482
[TBL] [Abstract][Full Text] [Related]
9. Systematic Review of Health Economic Impact Evaluations of Risk Prediction Models: Stop Developing, Start Evaluating.
van Giessen A; Peters J; Wilcher B; Hyde C; Moons C; de Wit A; Koffijberg E
Value Health; 2017 Apr; 20(4):718-726. PubMed ID: 28408017
[TBL] [Abstract][Full Text] [Related]
10. Pharmaceutical policies: effects of financial incentives for prescribers.
Rashidian A; Omidvari AH; Vali Y; Sturm H; Oxman AD
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD006731. PubMed ID: 26239041
[TBL] [Abstract][Full Text] [Related]
11. [A systematic review on population-based indicators of the quality of care in formal and informal provider networks and their application in health economic evaluations].
Seibert K; Stiefler S; Domhoff D; Wolf-Ostermann K; Peschke D
Z Evid Fortbild Qual Gesundhwes; 2019 Aug; 144-145():7-23. PubMed ID: 31327735
[TBL] [Abstract][Full Text] [Related]
12. The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.
McGhan WF; Al M; Doshi JA; Kamae I; Marx SE; Rindress D
Value Health; 2009; 12(8):1086-99. PubMed ID: 19744291
[TBL] [Abstract][Full Text] [Related]
13. Budget Impact Analysis of Diabetes Drugs: A Systematic Literature Review.
Luo Z; Ruan Z; Yao D; Ung COL; Lai Y; Hu H
Front Public Health; 2021; 9():765999. PubMed ID: 34869180
[No Abstract] [Full Text] [Related]
14. The clinical effectiveness and cost-effectiveness of home-based, nurse-led health promotion for older people: a systematic review.
Tappenden P; Campbell F; Rawdin A; Wong R; Kalita N
Health Technol Assess; 2012; 16(20):1-72. PubMed ID: 22490205
[TBL] [Abstract][Full Text] [Related]
15. Patient preferences for the treatment of type 2 diabetes: a scoping review.
Joy SM; Little E; Maruthur NM; Purnell TS; Bridges JF
Pharmacoeconomics; 2013 Oct; 31(10):877-92. PubMed ID: 24081453
[TBL] [Abstract][Full Text] [Related]
16. The use of economic evaluations in NHS decision-making: a review and empirical investigation.
Williams I; McIver S; Moore D; Bryan S
Health Technol Assess; 2008 Apr; 12(7):iii, ix-x, 1-175. PubMed ID: 18373906
[TBL] [Abstract][Full Text] [Related]
17. Including adverse drug events in economic evaluations of anti-tumour necrosis factor-α drugs for adult rheumatoid arthritis: a systematic review of economic decision analytic models.
Heather EM; Payne K; Harrison M; Symmons DP
Pharmacoeconomics; 2014 Feb; 32(2):109-34. PubMed ID: 24338344
[TBL] [Abstract][Full Text] [Related]
18. Systematic review and quality assessment of economic evaluations and quality-of-life studies related to generalized anxiety disorder.
Bereza BG; Machado M; Einarson TR
Clin Ther; 2009 Jun; 31(6):1279-308. PubMed ID: 19695395
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
